Related Experiment Video
Updated: Jul 2, 2025

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
Published on: January 19, 2024
Oral mucous membrane pemphigoid: updates in diagnosis and management
Roopali Kulkarni1, Eric T Stoopler2, Thomas P Sollecito3
1Assistant Professor of Oral Medicine, Department of Oral Medicine, University of Pennsylvania School of Dental Medicine, Philadelphia, Pennsylvania, USA.
Abstract:
Mucous membrane pemphigoid (MMP) is a rare, immune-mediated, vesiculobullous disease that predominantly affects the oral cavity and conjunctiva. In MMP, autoantibodies are directed against hemidesmosomal proteins in the basement membrane zone, most commonly BP180. Clinical signs and symptoms include gingival desquamation, erosions, and ulcerations. Differential diagnoses include other immune-mediated blistering diseases, such as bullous pemphigoid. Definitive diagnosis is reached through history taking, physical examination, tissue biopsy and/or serology testing. MMP, although not curable, is typically managed with topical or systemic corticosteroids, in addition to immunosuppressive therapies and biologic agents in recalcitrant cases. Untreated MMP can lead to life-threatening complications, such as blindness. As a condition that affects the oral cavity, it is important that dentists understand how to recognise, diagnose and manage the disease.
Insights
Mucous membrane pemphigoid (MMP) is a rare autoimmune blistering disease affecting oral and conjunctival tissues. Early recognition and management by dentists are crucial to prevent severe complications like blindness.
Area of Science:
- Oral Medicine
- Dermatology
- Immunology
Background:
- Mucous membrane pemphigoid (MMP) is a rare, chronic autoimmune blistering disease.
- It primarily affects mucous membranes, particularly the oral cavity and conjunctiva.
- Autoantibodies target hemidesmosomal proteins, commonly BP180, in the basement membrane zone.
Purpose of the Study:
- To provide an overview of mucous membrane pemphigoid.
- To highlight the importance of dental professionals in recognizing and managing MMP.
- To discuss diagnostic criteria and treatment strategies for MMP.
Main Methods:
- Literature review of autoimmune blistering diseases.
- Analysis of clinical presentation, diagnosis, and management of MMP.
- Emphasis on differential diagnosis from other vesiculobullous conditions.
Main Results:
- MMP presents with gingival desquamation, erosions, and ulcerations.
- Diagnosis relies on clinical findings, biopsy, and serology.
- Effective management involves corticosteroids, immunosuppressants, and biologics for severe cases.
Conclusions:
- MMP requires prompt diagnosis and multidisciplinary management.
- Dentists play a vital role in the early detection and care of oral manifestations of MMP.
- Timely intervention is essential to prevent potentially blinding complications.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Chronic Pancreatitis II: Collaborative Care
Assessment:

